Study tests if newer insulin is worth the cost for kids in need
NCT ID NCT05614089
Summary
This study aimed to find out if a newer, more expensive type of insulin (glargine) works better than older, cheaper human insulin for young people with type 1 diabetes in low-resource settings. It involved 400 participants aged 7-25 and measured how well each insulin controlled blood sugar levels and reduced the risk of dangerously low blood sugar over 6 and 12 months. The goal was to provide clear evidence to help guide affordable and effective treatment choices worldwide.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BIRDEM Hospital
Dhaka, Bangladesh
-
Bugando Medical Center
Mwanza, Tanzania
-
Sekou-Toure Hospital
Mwanza, Tanzania
Conditions
Explore the condition pages connected to this study.